Cargando…

Editorial: Biomarkers in CKD

Detalles Bibliográficos
Autores principales:	Araujo, Magali, Doi, Sonia Q.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649135/ https://www.ncbi.nlm.nih.gov/pubmed/29085823 http://dx.doi.org/10.3389/fmed.2017.00168

Ejemplares similares

Editorial: Management of Patients With Non-dialysis Dependent Chronic Kidney Disease (ND-CKD)
por: Provenzano, Michele, et al.
Publicado: (2022)

Optimizing Diet to Slow CKD Progression
por: Molina, Pablo, et al.
Publicado: (2021)

Hyperkalemia in CKD: an overview of available therapeutic strategies
por: Costa, Davide, et al.
Publicado: (2023)

Impact of Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) GFR Estimating Equations on CKD Prevalence and Classification Among Asians
por: Betzler, Bjorn Kaijun, et al.
Publicado: (2022)

Editorial: Inflammation and Biomarkers in Osteoarthritis
por: Mobasheri, Ali, et al.
Publicado: (2021)

Editorial: Biomarkers in Pulmonary Diseases
por: Mahboub, Bassam, et al.
Publicado: (2022)

Global Public Interest in CKD Based on Internet Searches
por: Liu, Yang, et al.
Publicado: (2021)

Editorial: Mineral and Bone Disorder in CKD
por: Printza, Nikoleta, et al.
Publicado: (2022)

Editorial: Personalized medicine in CKD patients
por: Eisenga, Michele F., et al.
Publicado: (2023)

Editorial: Omics biomarkers in inflammatory ocular diseases
por: Ttakeuchi, Masaru, et al.
Publicado: (2022)

Outcomes of COVID-19 Among Hospitalized Patients With Non-dialysis CKD
por: Coca, Armando, et al.
Publicado: (2020)

Editorial: Thrombotic Microangiopathies, Diagnostic and Therapeutic Advances
por: Maitta, Robert W., et al.
Publicado: (2021)

Editorial: Insights Into Biomarkers, Cytokines, and Chemokines in Skin Cancer
por: Barrett, Lucy W., et al.
Publicado: (2019)

Editorial: Organ Fibrosis: Pathogenesis, Biomarkers and Therapeutic Targets
por: Mutsaers, Henricus A. M., et al.
Publicado: (2021)

Editorial: Recent advances and new biomarkers in ulcerative colitis
por: Velikova, Tsvetelina, et al.
Publicado: (2023)

Editorial: Update on diagnostic and prognostic biomarkers for women's cancers
por: Zhu, Yunxia, et al.
Publicado: (2023)

Editorial: Torquetenovirus: predictive biomarker or innocent bystander in pathogenesis
por: Tozetto-Mendoza, Tania Regina, et al.
Publicado: (2023)

Integrative Informatics Analysis of Transcriptome and Identification of Interacted Genes in the Glomeruli and Tubules in CKD
por: Liu, Lingyun, et al.
Publicado: (2021)

Association of handgrip strength with new-onset CKD in Korean adults according to gender
por: Lee, Sung-Bum, et al.
Publicado: (2023)

Editorial: Developments in sickle cell disease therapy and potentials for gene therapy
por: Maitta, Robert W., et al.
Publicado: (2023)

Editorial: Recent advances on omics and biomarkers research in renal transplantation
por: Ding, Xiaoming, et al.
Publicado: (2023)

Experimental Aristolochic Acid Nephropathy: A Relevant Model to Study AKI-to-CKD Transition
por: Baudoux, Thomas, et al.
Publicado: (2022)

Effects of Normal Reference Range of Phosphorus and Corresponding PTH on Endothelial Function in CKD Patients
por: Lee, Shina, et al.
Publicado: (2022)

Development and validation of Chronic Kidney Disease Knowledge, Attitude, and Practices (CKD-KAP) questionnaire
por: Tariq, Muhammad Haseeb, et al.
Publicado: (2022)

Altered gut microbiome plays an important role in AKI to CKD transition in aged mice
por: Kim, Myung-Gyu, et al.
Publicado: (2023)

Editorial: The role of novel hepatitis B biomarkers in solving therapeutic dilemmas
por: Lazarevic, Ivana, et al.
Publicado: (2023)

Editorial: Tumor adaptation to cellular stresses: mechanisms, biomarkers and therapeutic opportunities
por: Cortesi, Michela, et al.
Publicado: (2023)

Association of Exercise With Vascular Function in Patients With CKD: A Meta-Analysis of Randomized Controlled Trials
por: Wang, Huan, et al.
Publicado: (2022)

Muscle fibrosis and maladaptation occur progressively in CKD and are rescued by dialysis
por: Brightwell, Camille R., et al.
Publicado: (2021)

Editorial: Management of pancreatic cancer: Defining the targets for therapy
por: Nguyen, Nam Q.
Publicado: (2022)

Editorial: Classical and Novel Biomarkers for Cardiovascular Disease
por: Perticone, Maria, et al.
Publicado: (2022)

Nephroprotection by SGLT2i in CKD Patients: May It Be Modulated by Low-Protein Plant-Based Diets?
por: Cupisti, Adamasco, et al.
Publicado: (2020)

Development of a new prognostic index PNPI for prognosis prediction of CKD patients with pneumonia at hospital admission
por: Cai, Xiao-Yu, et al.
Publicado: (2023)

Plasma Biomarkers as Risk Factors for Incident CKD
por: Sarnak, Mark J., et al.
Publicado: (2022)

Editorial: Novel biomarkers for clinical and molecular stratification of organ involvement in rheumatic diseases
por: Sun, Xiaolin, et al.
Publicado: (2023)

Editorial: The kidney in auto-immune and auto-inflammatory processes: Definitions, mechanisms, and biomarkers
por: Vaglio, Augusto, et al.
Publicado: (2023)

Urinary EGF and MCP-1 and risk of CKD after cardiac surgery
por: Menez, Steven, et al.
Publicado: (2021)

Metabolite profiling of CKD progression in the chronic renal insufficiency cohort study
por: Wen, Donghai, et al.
Publicado: (2022)

Editorial: Profiling the tumour microenvironment to unveil biomarkers and develop novel therapeutics for cancer therapy
por: Jaillon, Sebastien, et al.
Publicado: (2023)

Editorial: Aldehyde dehydrogenase in clinical settings: Potential biomarker and therapeutic target in solid tumors
por: Aramini, Beatrice, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7rmoog2rk79acphg6l9oekp27m